Related Experiment Video
Updated: Jul 23, 2025
06:08
Author Spotlight: A Pseudotype Virus System for Assessing Omicron Subvariants and Neutralizing Antibodies in SARS-CoV-2 Research
Published on: September 8, 2023
1.3K
Estimating long-term vaccine effectiveness against SARS-CoV-2 variants: a model-based approach.
Alexandra B Hogan1,2, Patrick Doohan2, Sean L Wu3
1School of Population Health, Faculty of Medicine and Health, University of New South Wales, Sydney, NSW, Australia.
Nature Communications
|July 19, 2023
Summary
Updated COVID-19 vaccines targeting Omicron variants may significantly reduce hospitalizations and deaths. While current vaccines offer protection, a variant-matched booster is projected to be nearly twice as effective over one year.
Area of Science:
- Virology
- Immunology
- Epidemiology
Background:
- The SARS-CoV-2 virus continues to evolve, necessitating updated vaccine strategies.
- Assessing vaccine effectiveness against new variants like Omicron is crucial for public health.
Purpose of the Study:
- To model the effectiveness of COVID-19 vaccines against SARS-CoV-2 variants.
- To project the impact of variant-matched vaccines on hospitalizations and deaths.
Main Methods:
- Utilized a mathematical model linking immunity levels to vaccine effectiveness data.
- Analyzed data from England for three major vaccines (Oxford/AstraZeneca, Pfizer-BioNTech, Moderna).
- Included data for Delta and Omicron variants.
Main Results:
- The model accurately reproduced sustained protection against Omicron hospitalization and death for six months post-dose 3 with ancestral vaccines.
- Protection against Omicron is projected to wane to moderate levels after one year.
- A fourth dose with an Omicron BA.1/2-matched vaccine is projected to prevent nearly twice as many hospitalizations and deaths over one year compared to an ancestral vaccine.
Conclusions:
- Variant-matched COVID-19 vaccines show potential for significantly improved protection.
- The findings highlight the importance of updated vaccines in combating viral evolution.
- Further research is needed to address uncertainties in predicting vaccine effectiveness and the role of infection-induced immunity.
Related Concept Videos
01:14Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
184
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
184
01:26Pharmacokinetic Models: Comparison and Selection Criterion
109
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
109
01:15Model Approaches for Pharmacokinetic Data: Physiological Models
78
Physiological models in pharmacokinetics are instrumental in understanding the distribution and elimination of drugs within the body. These models describe the drug concentration within target organs, influenced by factors such as drug uptake, tissue volume, and blood flow. Drug uptake is governed by the partition coefficient, which signifies the drug concentration ratio in tissue to that in the blood. The blood flow rate to a specific tissue is expressed as Qt, and the rate of change in tissue...
78
01:06Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
96
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
96
01:20Pharmacokinetic Models: Overview
794
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
794
01:14Model Approaches for Pharmacokinetic Data: Compartment Models
139
Compartmental analysis is a widely adopted approach to characterizing drug pharmacokinetics. It uses compartment models that conceptualize the body as a collection of reversibly communicating compartments, each representing a group of tissues exhibiting similar drug distribution characteristics. The movement rate of the drug between these compartments is typically described by first-order kinetics.
Two primary types of compartment models are recognized: mammillary and catenary. The more...
Two primary types of compartment models are recognized: mammillary and catenary. The more...
139